Return on Assets (ROA): 6.14%
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 6.14% is 26% below its 5-year average of 8.30%, near the low end of its 5-year range (5.39%–14.66%).
As of Friday, June 26, 2026. 6.78% above its 12-month average of 5.75%.
DGX Return on Assets (ROA) Chart
Annual fiscal-year return on assets; no daily interpolation.
DGX Average Return on Assets (ROA) Chart
DGX Current vs Average Return on Assets (ROA) Chart
DGX Return on Assets (ROA) Metrics
RETURN ON ASSETS (ROA)
6.14%
RETURN ON ASSETS (ROA) AVG TTM
5.75%
RETURN ON ASSETS (ROA) AVG 3Y
6.24%
RETURN ON ASSETS (ROA) AVG 5Y
8.30%
RETURN ON ASSETS (ROA) AVG 10Y
7.64%
RETURN ON ASSETS (ROA) AVG 15Y
6.70%
RETURN ON ASSETS (ROA) AVG 20Y
7.20%
CURRENT VS TTM AVG
+6.78%
CURRENT VS 3Y AVG
-1.60%
CURRENT VS 5Y AVG
-26.05%
CURRENT VS 10Y AVG
-19.64%
CURRENT VS 15Y AVG
-8.36%
CURRENT VS 20Y AVG
-14.76%
DGX Competitors' Return on Assets (ROA)
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated (DGX) | $22.83B | 6.14% | 5.75% | 6.24% | 8.30% |
| BioNTech SE (BNTX)vs › | $22.76B | -6.03% | -3.96% | 9.16% | 17.06% |
| United Therapeutics Corporation (UTHR)vs › | $23.07B | 19.17% | 16.59% | 14.73% | 13.22% |
| Moderna, Inc. (MRNA)vs › | $23.71B | -27.80% | -24.02% | -10.32% | -0.33% |
| Labcorp Holdings Inc. (LH)vs › | $21.83B | 4.93% | 4.41% | 4.42% | 6.18% |
| Incyte Corporation (INCY)vs › | $21.48B | 19.51% | 9.54% | 8.43% | 7.44% |
| Waters Corporation (WAT)vs › | $24.57B | 1.83% | 13.34% | 15.53% | 17.15% |
| Mettler-Toledo International Inc. (MTD)vs › | $25.13B | 23.85% | 25.02% | 24.63% | 23.85% |
| STERIS plc (STE)vs › | $20.52B | 7.29% | 6.68% | 4.44% | 4.33% |
| Veeva Systems Inc. (VEEV)vs › | $25.68B | 10.31% | 9.93% | 9.72% | 10.43% |
Asset Efficiency
ROA
6.1%
ROE
13.9%
Return on Assets (ROA) Formula & Definition
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Return on Assets (ROA) FAQ
- What is the return on assets (ROA) for Quest Diagnostics Incorporated (DGX)?
- The return on assets (ROA) for DGX stock is 6.14%.
- Is Quest Diagnostics Incorporated's return on assets (ROA) high or low?
- The return on assets (ROA) of 6.14% is 26% below its 5-year average of 8.30%, near the low end of its 5-year range (5.39%–14.66%).
- What is the TTM average return on assets (ROA) for Quest Diagnostics Incorporated (DGX)?
- The TTM average return on assets (ROA) for DGX stock is 5.75%.
- What is the 3Y average return on assets (ROA) for Quest Diagnostics Incorporated (DGX)?
- The 3Y average return on assets (ROA) for DGX stock is 6.24%.
- What is the 5Y average return on assets (ROA) for Quest Diagnostics Incorporated (DGX)?
- The 5Y average return on assets (ROA) for DGX stock is 8.30%.
- What is the 10Y average return on assets (ROA) for Quest Diagnostics Incorporated (DGX)?
- The 10Y average return on assets (ROA) for DGX stock is 7.64%.
- What is the 15Y average return on assets (ROA) for Quest Diagnostics Incorporated (DGX)?
- The 15Y average return on assets (ROA) for DGX stock is 6.70%.
- What is the 20Y average return on assets (ROA) for Quest Diagnostics Incorporated (DGX)?
- The 20Y average return on assets (ROA) for DGX stock is 7.20%.
DGX Return on Assets (ROA) History
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 6.11% |
| 2024-12-31 | 5.39% |
| 2023-12-31 | 6.09% |
| 2022-12-31 | 7.37% |
| 2021-12-31 | 14.66% |
| 2020-12-31 | 10.20% |
| 2019-12-31 | 6.68% |
| 2018-12-31 | 6.69% |
| 2017-12-31 | 7.35% |
| 2016-12-31 | 6.39% |
| 2015-12-31 | 7.12% |
| 2014-12-31 | 5.63% |
| 2013-12-31 | 9.49% |
| 2012-12-31 | 5.99% |
| 2011-12-31 | 5.05% |
| 2010-12-31 | 8.45% |
| 2009-12-31 | 8.51% |
| 2008-12-31 | 6.92% |
| 2007-12-31 | 3.97% |
| 2006-12-31 | 10.36% |
| 2005-12-31 | 10.30% |
| 2004-12-31 | 11.87% |
| 2003-12-31 | 10.15% |
| 2002-12-31 | 9.69% |
| 2001-12-31 | 5.54% |
| 2000-12-31 | 3.56% |
| 1999-12-31 | -0.12% |
| 1998-12-31 | 1.98% |
| 1997-12-31 | -1.59% |
| 1996-12-31 | -44.87% |
Related Metrics
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James E. Davis